File(s) under permanent embargo
Clinical and prognostic implications of existing and new-onset atrial fibrillation in patients undergoing transcatheter aortic valve implantation
journal contributionposted on 2013-05-01, 00:00 authored by Michael MokMichael Mok, M Urena, L Nombela-Franco, H B Ribeiro, R Allende, R Delarochellière, D Doyle, E Dumont, M Côté, J Rodés-Cabau
Atrial fibrillation (AF) is a common co-morbidity among patients undergoing Transcatheter Aortic Valve Implantation (TAVI). Only recently have the clinical outcomes of patients with chronic or new-onset AF after TAVI been reported. The absence of clinical trials focusing on this cohort of patients has resulted in the lack of evidence based clinical guidelines. We aim to review and discuss the current literature on AF in TAVI, its clinical implications and future perspectives.
JournalJournal of thrombosis and thrombolysis
Pagination450 - 455
LocationNew York, N.Y.
Publication classificationC1.1 Refereed article in a scholarly journal; C Journal article
Copyright notice2012, Springer Science+Business Media New York
AgedAged, 80 and overAortic ValveAtrial FibrillationCardiac CatheterizationFemaleHeart Defects, CongenitalHeart Valve DiseasesHeart Valve ProsthesisHumansMaleMiddle AgedPostoperative ComplicationsScience & TechnologyLife Sciences & BiomedicineCardiac & Cardiovascular SystemsHematologyPeripheral Vascular DiseaseCardiovascular System & CardiologyTranscatheter aortic valve implantationAntithromboticStrokeACUTE CORONARY SYNDROMESRISK-FACTORSANTITHROMBOTIC THERAPYCEREBROVASCULAR EVENTSCONSENSUS DOCUMENTPREDICTIVE FACTORSLATE OUTCOMESPREVALENCESTENOSISSURGERY